Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sakamoto

Showing results (21-30 of 1,255) with videos related to

Pageof 126
Sort By:
Methods in Enzymology|December 13, 2005
Chimeric molecules to target proteins for ubiquitination and degradationKathleen M Sakamoto
Journal of Leukocyte Biology|October 4, 2011
Editorial: granulopoiesis versus monopoiesis: a consequence of transcription factors dancing with the right partnersKathleen M Sakamoto
Idrugs : the Investigational Drugs Journal|June 21, 2005
Semaxanib (SUGEN)K M Sakamoto
Current Opinion in Investigational Drugs (London, England : 2000)|January 15, 2005
Su-11248 SugenKathleen M Sakamoto
Leukemia & Lymphoma|November 12, 2013
Letting microRNAs overcome resistance to chemotherapy in acute myeloid leukemiaKathleen M Sakamoto
Blood|June 10, 2017
Lost in translation: RP and <i>GATA1</i> mutations in DBAKathleen M Sakamoto
Molecular Genetics and Metabolism|October 3, 2002
Ubiquitin-dependent proteolysis: its role in human diseases and the design of therapeutic strategiesKathleen M Sakamoto
Leukemia|September 26, 2024
Can PROTACs cure Leukemia?Kathleen M Sakamoto
Idrugs : the Investigational Drugs Journal|December 23, 2003
Targeting ubiquitinylation for drug discoveryKathleen M Sakamoto
Pediatric Research|April 23, 2004
Knocking down human disease: potential uses of RNA interference in research and gene therapyKathleen M Sakamoto
Pageof 126

Showing results (21-30 of 1,255) with videos related to

Sort By:
Pageof 126
Methods in Enzymology|December 13, 2005
Chimeric molecules to target proteins for ubiquitination and degradationKathleen M Sakamoto
Journal of Leukocyte Biology|October 4, 2011
Editorial: granulopoiesis versus monopoiesis: a consequence of transcription factors dancing with the right partnersKathleen M Sakamoto
Idrugs : the Investigational Drugs Journal|June 21, 2005
Semaxanib (SUGEN)K M Sakamoto
Current Opinion in Investigational Drugs (London, England : 2000)|January 15, 2005
Su-11248 SugenKathleen M Sakamoto
Leukemia & Lymphoma|November 12, 2013
Letting microRNAs overcome resistance to chemotherapy in acute myeloid leukemiaKathleen M Sakamoto
Blood|June 10, 2017
Lost in translation: RP and <i>GATA1</i> mutations in DBAKathleen M Sakamoto
Molecular Genetics and Metabolism|October 3, 2002
Ubiquitin-dependent proteolysis: its role in human diseases and the design of therapeutic strategiesKathleen M Sakamoto
Leukemia|September 26, 2024
Can PROTACs cure Leukemia?Kathleen M Sakamoto
Idrugs : the Investigational Drugs Journal|December 23, 2003
Targeting ubiquitinylation for drug discoveryKathleen M Sakamoto
Pediatric Research|April 23, 2004
Knocking down human disease: potential uses of RNA interference in research and gene therapyKathleen M Sakamoto
Pageof 126